Juno Therapeutics , a Seattle-based developer of immunotherapies for cancer, has closed its Series A round with $176 million in capital commitments .
↧
Channel:
Topix
X
Are you the publisher?
Claim or
contact us
about this channel.
X
0
Channel Details:
- Title: Topix
- Channel Number: 6842807
- Language: English
- Registered On: December 20, 2012, 9:32 pm
- Number of Articles: 326
- Latest Snapshot: June 11, 2020, 7:14 pm
- RSS URL: http://www.topix.com/rss/com/payscale
- Publisher: https://stars.topix.com/
- Description:
- Catalog: //payscale4.rssing.com/catalog.php?indx=6842807
© 2026 //www.rssing.com